Genenta Science S.p.A. Deferred Offering Costs
Genenta Science S.p.A. (GNTA) had Deferred Offering Costs of EUR 1.10 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2026-04-01
- 2025-12-31: Deferred Offering Costs 1.10M EUR.
- 2020-12-31: Deferred Offering Costs 156.26K EUR.
| Period end | Deferred Offering Costs |
|---|---|
| 2025-12-31 | 1.10M EUR 20-F · filed 2026-04-01 |
| 2020-12-31 | 156.26K EUR 20-F · filed 2022-05-02 |